Authors: Anne Adams.(University of Cologne- Medical Faculty, Institute of Medical Statistics and Computational Biology, Köln, Germany), Christian Baues.(University Hospital of Cologne, Center for Integrated Oncology CIO, Köln, Germany), Christian Baues.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Christian Baues.(University Hospital of Cologne, Radio Immune-Oncology Consortium RIO, Köln, Germany), Eren Celik.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Martin Hellmich.(University of Cologne- Medical Faculty, Institute of Medical Statistics and Computational Biology, Köln, Germany), Jan M. Herter.(University Hospital of Cologne, Center for Integrated Oncology CIO, Köln, Germany), Jan M. Herter.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Jan M. Herter.(University of Cologne, Center for Molecular Medicine Cologne CMMC, Köln, Germany), Jaika Kinsky.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Simone Marnitz.(University Hospital of Cologne, Center for Integrated Oncology CIO, Köln, Germany), Simone Marnitz.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Simone Marnitz.(University Hospital of Cologne, Radio Immune-Oncology Consortium RIO, Köln, Germany), Janis Morgenthaler.(University Hospital of Cologne, Center for Integrated Oncology CIO, Köln, Germany), Janis Morgenthaler.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Max Schlaak.(University Hospital- LMU Munich, Department of Dermatology and Allergology, München, Germany), Max Schlaak.(University Hospital of Cologne, Radio Immune-Oncology Consortium RIO, Köln, Germany), Sebastian Theurich.(University Hospital- LMU Munich, Department of Medicine III, München, Germany), Sebastian Theurich.(University Hospital of Cologne, Radio Immune-Oncology Consortium RIO, Köln, Germany), Maike Trommer.(University Hospital of Cologne, Center for Integrated Oncology CIO, Köln, Germany), Maike Trommer.(University Hospital of Cologne, Department of Radiation Oncology, Köln, Germany), Maike Trommer.(University Hospital of Cologne, Radio Immune-Oncology Consortium RIO, Köln, Germany), Michael von Bergwelt-Baildon.(University Hospital- LMU Munich, Department of Medicine III, München, Germany), Michael von Bergwelt-Baildon.(University Hospital of Cologne, Radio Immune-Oncology Consortium RIO, Köln, Germany)
Show Affiliations
Hide Affiliations